Home LiteratureArticle Details
PMID: 9659359 Published · ppublish English Journal Article Review

Lung infections. 3. Pseudomonas aeruginosa and other related species.

Thorax ·Vol. 53 ·No. 3 ·1998-03-00 ·Pages 213-9

Wilson R, Dowling RB

Abstract

暂无摘要

MeSH Terms
Anti-Bacterial Agents/therapeutic use Cystic Fibrosis/microbiology Drug Resistance, Microbial Humans Inflammation Opportunistic Infections/immunology,microbiology,therapy Pseudomonas Infections/immunology,therapy Pseudomonas aeruginosa/pathogenicity Respiratory Tract Infections/immunology,microbiology,therapy
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wilson R
Host Defence Unit, Imperial College of Science, Technology and Medicine, National Heart and Lung Institute, London, UK.
Dowling R B
References (116)
116 references, click to expand
  1. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
    Pediatr Pulmonol. 1993 May;15(5):292-7 PMID: 8327288
  2. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis.
    Am Rev Respir Dis. 1993 Sep;148(3):793-805 PMID: 8368651
  3. Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa.
    Am J Respir Cell Mol Biol. 1993 Sep;9(3):323-34 PMID: 8398170
  4. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells.
    J Clin Invest. 1993 Oct;92(4):1875-80 PMID: 8104958
  5. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.
    J Clin Invest. 1994 Jan;93(1):26-32 PMID: 8282796
  6. Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.
    J Infect Dis. 1994 May;169(5):1159-62 PMID: 8169414
  7. New perspectives in understanding and management of the respiratory disease in cystic fibrosis.
    Eur J Pediatr. 1994 Mar;153(3):144-50 PMID: 8181493
  8. Intravenous antibiotic therapy in cystic fibrosis: in hospital or at home?
    Respir Med. 1993 Jul;87(5):329-30 PMID: 8209051
  9. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis.
    Respir Med. 1994 Mar;88(3):203-11 PMID: 8209069
  10. Cells and cytokines in chronic bronchial infection.
    Ann N Y Acad Sci. 1994 May 28;725:331-45 PMID: 8031005
  11. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
    Am J Respir Crit Care Med. 1994 Aug;150(2):448-54 PMID: 8049828
  12. The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage.
    J Antimicrob Chemother. 1994 Apr;33(4):765-75 PMID: 8056695
  13. Mucociliary transport in trachea of patients with cystic fibrosis.
    Arch Dis Child. 1976 Jan;51(1):28-33 PMID: 942226
  14. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Acta Pathol Microbiol Scand Suppl. 1977;(262):1-96 PMID: 411327
  15. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.
    Infect Immun. 1979 Apr;24(1):188-93 PMID: 110691
  16. Hypogammaglobulinemia in patients with cystic fibrosis.
    N Engl J Med. 1980 Jan 31;302(5):245-9 PMID: 7350477
  17. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
    J Pediatr. 1980 Jul;97(1):144-7 PMID: 7381634
  18. Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells.
    Infect Immun. 1980 Sep;29(3):1146-51 PMID: 6107276
  19. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lancet. 1981 Nov 21;2(8256):1137-9 PMID: 6118579
  20. The role of Pseudomonas aeruginosa in infections.
    J Antimicrob Chemother. 1983 May;11 Suppl B:1-13 PMID: 6413479
  21. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.
    Acta Paediatr Scand. 1983 Sep;72(5):651-7 PMID: 6637463
  22. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids.
    Proc Natl Acad Sci U S A. 1988 Aug;85(16):6157-61 PMID: 3413084
  23. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation.
    J Infect Dis. 1989 May;159(5):966-73 PMID: 2540250
  24. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
    Antimicrob Agents Chemother. 1989 Jan;33(1):41-7 PMID: 2496657
  25. Pathogenesis of the pseudomonas lung lesion in cystic fibrosis.
    Chest. 1989 Jul;96(1):158-64 PMID: 2500307
  26. Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis.
    J Clin Invest. 1989 Jul;84(1):68-72 PMID: 2738159
  27. Melioidosis: review and update.
    Rev Infect Dis. 1989 May-Jun;11(3):413-25 PMID: 2665001
  28. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.
    J Clin Invest. 1989 Oct;84(4):1302-13 PMID: 2507578
  29. The immunological component of the cellular inflammatory infiltrate in bronchiectasis.
    Thorax. 1989 Aug;44(8):668-73 PMID: 2678579
  30. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.
    J Clin Microbiol. 1989 Nov;27(11):2589-93 PMID: 2572604
  31. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.
    Am Rev Respir Dis. 1989 Dec;140(6):1650-61 PMID: 2513765
  32. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro.
    Am Rev Respir Dis. 1990 Jan;141(1):72-8 PMID: 2404441
  33. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    Am Rev Respir Dis. 1990 Mar;141(3):605-12 PMID: 2310093
  34. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum.
    Eur Respir J. 1990 Jan;3(1):19-23 PMID: 2107097
  35. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells.
    J Clin Invest. 1990 Mar;85(3):682-9 PMID: 2107207
  36. Proinflammatory interactions of pyocyanin and 1-hydroxyphenazine with human neutrophils in vitro.
    J Infect Dis. 1990 Jul;162(1):178-85 PMID: 2162367
  37. Glycosphingolipid receptors for Pseudomonas aeruginosa.
    Infect Immun. 1990 Jul;58(7):2361-6 PMID: 2114364
  38. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms.
    Infect Immun. 1990 Jul;58(7):2383-5 PMID: 2114367
  39. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.
    J Clin Invest. 1990 Jul;86(1):300-8 PMID: 2164045
  40. Indium-111 labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectoration.
    Thorax. 1990 Jul;45(7):541-4 PMID: 2396234
  41. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.
    Lancet. 1990 Nov 3;336(8723):1094-6 PMID: 1977981
  42. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
    Microbiol Sci. 1986 Oct;3(10):302-8 PMID: 3155268
  43. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa.
    J Infect Dis. 1986 May;153(5):902-9 PMID: 3486235
  44. Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis.
    J R Soc Med. 1986;79 Suppl 12:13-8 PMID: 2425090
  45. Effects of erythromycin, josamycin and spiramycin on rat polymorphonuclear leukocyte chemotaxis.
    Chemotherapy. 1986;32(4):379-82 PMID: 3731922
  46. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro.
    J Clin Invest. 1987 Jan;79(1):221-9 PMID: 3098783
  47. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa.
    J Infect Dis. 1987 Jan;155(1):119-26 PMID: 3098862
  48. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
    J Antimicrob Chemother. 1987 Jun;19(6):831-8 PMID: 3301785
  49. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.
    J Pediatr. 1987 Oct;111(4):599-605 PMID: 3309236
  50. Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa.
    Br J Dis Chest. 1987 Jul;81(3):272-9 PMID: 3311119
  51. Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis.
    J Pediatr. 1987 Dec;111(6 Pt 1):907-13 PMID: 3316565
  52. Impaired tracheobronchial clearance in bronchiectasis.
    Thorax. 1987 Feb;42(2):126-30 PMID: 3433236
  53. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium.
    Am J Respir Cell Mol Biol. 1991 Jan;4(1):26-32 PMID: 1898852
  54. Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal beta 1-3GlcNAc) or type 2 (Gal beta 1-4GlcNAc) disaccharide units.
    Infect Immun. 1991 Feb;59(2):700-4 PMID: 1670932
  55. Risks of alternate-day prednisone in patients with cystic fibrosis.
    Pediatrics. 1991 Feb;87(2):245-6 PMID: 1987537
  56. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    J Clin Invest. 1991 Feb;87(2):482-8 PMID: 1671391
  57. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
    Lancet. 1991 Feb 16;337(8738):392-4 PMID: 1671425
  58. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function.
    Pediatr Pulmonol. 1991;10(2):92-100 PMID: 1903199
  59. Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture.
    J Clin Invest. 1991 Jun;87(6):2018-28 PMID: 1904070
  60. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening.
    J Pediatr. 1991 Aug;119(2):211-7 PMID: 1907318
  61. Stimulation of secretion into human and feline airways by Pseudomonas aeruginosa proteases.
    J Appl Physiol (1985). 1991 May;70(5):2259-67 PMID: 1907606
  62. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    J Clin Microbiol. 1991 Jun;29(6):1265-7 PMID: 1907611
  63. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody.
    J Infect Dis. 1991 Sep;164(3):507-14 PMID: 1831226
  64. Pseudomonas aeruginosa exoenzyme S is an adhesion.
    Infect Immun. 1991 Sep;59(9):2859-63 PMID: 1679039
  65. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
    Lancet. 1991 Sep 21;338(8769):725-6 PMID: 1679870
  66. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
    Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):580-5 PMID: 1892298
  67. An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces.
    J Biomed Mater Res. 1991 Jul;25(7):865-74 PMID: 1918103
  68. Release of mucus glycoconjugates by Pseudomonas aeruginosa rhamnolipid into feline trachea in vivo and human bronchus in vitro.
    Am J Respir Cell Mol Biol. 1992 Jan;6(1):116-22 PMID: 1728290
  69. Restriction enzyme and Southern hybridization analyses of Pseudomonas aeruginosa strains from patients with cystic fibrosis.
    J Clin Microbiol. 1991 Dec;29(12):2897-900 PMID: 1684586
  70. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
    J Clin Invest. 1992 Feb;89(2):657-65 PMID: 1737853
  71. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    N Engl J Med. 1992 Mar 19;326(12):812-5 PMID: 1538726
  72. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Thorax. 1992 Jan;47(1):6-13 PMID: 1539148
  73. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.
    Arch Dis Child. 1992 Feb;67(2):192-5 PMID: 1371914
  74. Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa.
    Infect Immun. 1992 Apr;60(4):1530-5 PMID: 1548076
  75. Pseudomonas cepacia in cystic fibrosis.
    Thorax. 1994 Jul;49(7):629-30 PMID: 7520606
  76. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis.
    N Engl J Med. 1994 Oct 13;331(15):981-7 PMID: 7521938
  77. Oxidant-mediated ciliary dysfunction in human respiratory epithelium.
    Free Radic Biol Med. 1994 Jul;17(1):1-10 PMID: 7959161
  78. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis.
    J Antimicrob Chemother. 1994 Jul;34(1):149-56 PMID: 7961201
  79. Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis.
    Pediatr Pulmonol. 1994 Aug;18(2):108-13 PMID: 7526323
  80. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    J Infect Dis. 1994 Dec;170(6):1616-21 PMID: 7996008
  81. Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro.
    Eur Respir J. 1994 Oct;7(10):1746-53 PMID: 7828679
  82. In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation.
    J Antimicrob Chemother. 1994 Sep;34(3):331-41 PMID: 7829408
  83. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator.
    J Pediatr. 1995 Feb;126(2):230-3 PMID: 7531240
  84. Effect of high-dose ibuprofen in patients with cystic fibrosis.
    N Engl J Med. 1995 Mar 30;332(13):848-54 PMID: 7503838
  85. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface.
    Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):3019-23 PMID: 7708767
  86. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.
    BMJ. 1995 Jun 17;310(6994):1571-2 PMID: 7787647
  87. Characterization of Pseudomonas aeruginosa fliO, a gene involved in flagellar biosynthesis and adherence.
    Infect Immun. 1995 Aug;63(8):2950-7 PMID: 7622217
  88. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 1995 Apr;35(4):521-34 PMID: 7628986
  89. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
    Science. 1996 Jan 5;271(5245):64-7 PMID: 8539601
  90. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.
    Cell. 1996 Apr 19;85(2):229-36 PMID: 8612275
  91. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.
    Thorax. 1996 Apr;51(4):364-8 PMID: 8733486
  92. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Lancet. 1996 Sep 7;348(9028):639-42 PMID: 8782753
  93. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.
    Eur Respir J. 1996 Aug;9(8):1601-4 PMID: 8866579
  94. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium.
    Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 2):S155-62 PMID: 8876535
  95. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
    Cell. 1997 Feb 21;88(4):553-60 PMID: 9038346
  96. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
    Eur Respir J. 1997 Aug;10(8):1754-60 PMID: 9272915
  97. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
    J Pediatr. 1984 Feb;104(2):206-10 PMID: 6420530
  98. Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium.
    Infect Immun. 1984 Apr;44(1):38-40 PMID: 6142863
  99. Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin.
    Infect Immun. 1984 Jul;45(1):197-202 PMID: 6429045
  100. Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.
    Infect Immun. 1985 Jan;47(1):1-4 PMID: 3155514
  101. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.
    J Infect Dis. 1985 Apr;151(4):575-80 PMID: 3919113
  102. Tracheobronchial mucin receptor for Pseudomonas aeruginosa: predominance of amino sugars in binding sites.
    Infect Immun. 1985 May;48(2):331-5 PMID: 2985503
  103. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.
    J Pediatr. 1985 Sep;107(3):382-7 PMID: 4032134
  104. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.
    Lancet. 1985 Sep 28;2(8457):686-8 PMID: 2863676
  105. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis.
    Am Rev Respir Dis. 1985 Sep;132(3):529-35 PMID: 3898942
  106. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Am Rev Respir Dis. 1986 Apr;133(4):648-52 PMID: 3083745
  107. A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis.
    Br J Dis Chest. 1987 Oct;81(4):356-60 PMID: 3329531
  108. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
    J Clin Invest. 1992 May;89(5):1478-84 PMID: 1569186
  109. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects.
    Infect Immun. 1992 Jul;60(7):2808-14 PMID: 1612746
  110. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    J Clin Invest. 1992 Oct;90(4):1296-301 PMID: 1357002
  111. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.
    Antimicrob Agents Chemother. 1992 Jun;36(6):1176-80 PMID: 1416817
  112. Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis.
    Lancet. 1993 Jan 23;341(8839):189-93 PMID: 7678316
  113. Adhesins and receptors of Pseudomonas aeruginosa associated with infection of the respiratory tract.
    Microb Pathog. 1992 Oct;13(4):251-60 PMID: 1363702
  114. Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
    N Engl J Med. 1993 Jun 17;328(24):1740-6 PMID: 8497284
  115. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis.
    Respir Med. 1993 Apr;87(3):187-92 PMID: 7684530
  116. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
    Pediatr Pulmonol. 1993 Mar;15(3):135-9 PMID: 8327274
Article Info
Journal
Thorax
Abbr.
Thorax
ISSN
0040-6376
DOI
10.1136/thx.53.3.213
Published
1998-03-00
Pages
213-9
Language
English
Region
England
NLM ID
0417353
PMCID
PMC1745165
Subset
IM
External Links
PubMed source DOI: 10.1136/thx.53.3.213 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2